Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)

Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Michael J. Carr, Avinash Sharma, Edmund K. Bartlett, Amanda A.G. Nijhuis, John F. Thompson, Tina J. Hieken, Lisa Kottschade, Jennifer Downs, David E. Gyorki, Emma Stahlie, Alexander van Akkooi, David W. Ollila, Jill Frank, Yun Song, Giorgos KarakousisMarc Moncrieff, Jenny Nobes, John Vetto, Dale Han, Jeffrey M. Farma, Jeremiah L. Deneve, Martin D. Fleming, Matthew C. Perez, Michael C. Lowe, Roger Olofsson Bagge, Jan Mattsson, Ann Y. Lee, Russell S. Berman, Harvey Chai, Hidde M. Kroon, Juri Teras, Roland M. Teras, Norma E. Farrow, Georgia Beasley, Jane Yuet Ching Hui, Lukas Been, Schelto Kruijff, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)'. Together they form a unique fingerprint.

Medicine & Life Sciences